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Abstract
Diagnosis of Alzheimer’s disease is based on the results of neuropsychological tests and available supporting biomarkers
such as the results of imaging studies. The results of the tests and the values of biomarkers are dependent on the nuisance
features, such as age and gender. In order to improve diagnostic power, the effects of the nuisance features have to be
removed from the data. In this paper, four types of interactions between classification features and nuisance features were
identified. Three methods were tested to remove these interactions from the classification data. In stratified analysis, a
homogeneous subgroup was generated from a training set. Data correction method utilized linear regression model to
remove the effects of nuisance features from data. The third method was a combination of these two methods. The
methods were tested using all the baseline data from the Alzheimer’s Disease Neuroimaging Initiative database in two
classification studies: classifying control subjects from Alzheimer’s disease patients and discriminating stable and
progressive mild cognitive impairment subjects. The results show that both stratified analysis and data correction are able
to statistically significantly improve the classification accuracy of several neuropsychological tests and imaging biomarkers.
The improvements were especially large for the classification of stable and progressive mild cognitive impairment subjects,
where the best improvements observed were 6% units. The data correction method gave better results for imaging
biomarkers, whereas stratified analysis worked well with the neuropsychological tests. In conclusion, the study shows that
the excess variability caused by nuisance features should be removed from the data to improve the classification accuracy,
and therefore, the reliability of diagnosis making.
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Introduction
Alzheimer’s disease (AD) is the most general type of dementia. It
is a neurodegenerative disease that causes atrophy in the cerebral
cortex and subcortical structures, such as the hippocampus and
amygdala. The latest research guidelines for the diagnosis of
probable Alzheimer’s disease require a presence of both
impairment in episodic memory and one supportive feature,
either medial temporal lobe atrophy, abnormal cerebrospinal fluid
biomarker, specific pattern in positron emission tomography or
proven AD autosomal dominant mutation [1–2]. Mild cognitive
impairment (MCI) is a condition in which a patient has memory
impairment but activities of daily living are preserved [3]. It is a
risk factor for AD, but not every MCI patient develops into AD.
Lots of interest has been recently focused on personalized
healthcare or medicine [4–6], where the population is divided into
sub-groups based on some personal factors, and the diagnosis and/
or treatment is decided using the information tailored specifically
to each sub-group. Typically, the sub-groups are determined based
on age, gender, or genome. Considering the diagnosis of AD,
demographic information of a patient, such as age, gender,
education, weight, and genome have been reported to interact
with the results of neuropsychological tests and biomarkers [7–10].
Consequently, personalized models are needed to improve the
diagnosis of AD.
In statistics, such variables that affect the analysis results but are
not of immediate interest are called as nuisance variables/
features/covariates. In this paper, methods to remove the effects
of nuisance features are studied. The methods studied benefit
personalized healthcare and medicine by producing optimally
personalized data that a clinician can utilize in the decision making
or that can produce more accurate classifications with automated
machine learning methods.
There are several ways to remove the data variability caused by
nuisance features. In clinical studies, the effects of personal factors
are often removed by using age- and gender-matched study
groups. A similar approach is to divide the data into more
homogeneous sub-groups (stratified analysis) [11]. For example,
one may make separate analyses for males and females, or divide
data into age groups, or do both. The nuisance data variability
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:should be smaller in these sub-groups, and the disease-related
variability should be more pronounced. In this paper, the term data
stratification is used to refer to a method where a subset of samples is
selected for the analysis based on the values of one or many
nuisance features. This is the typical approach used in personal-
ized healthcare and medication.
In statistics, analysis of covariance (ANCOVA) can be used to
remove the effects of nuisance features from the independent
variables (classification features, i.e., features used to classify the
subjects) by means of multiple linear regressions [12]. In this study,
a method related to ANCOVA is used to remove the effects of
nuisance features from the classification features prior classification
using a linear regression model. The term data correction is used to
refer to this method. In some studies, the nuisance features are
given as ordinary variables to the classifier, such as support vector
machine, and it is assumed that the classifier is able to correct the
interactions between nuisance features and classification features
[13]. Other methods to eliminate the nuisance features are
presented in [14], from which the most generally used methods are
based on Bayesian models.
In this paper, the methods to remove the interactions of
nuisance features and classification features were compared using
a large dataset and a large number of classification features from
several neuropsychological tests and a number of imaging
biomarkers. Three methods were tested. First, in data stratification
the data were divided into subgroups based on one or several
nuisance features. Second, in data correction the interactions of
the nuisance features were removed from the classification features
using a linear regression model. Our goal was to remove the effects
of nuisance features but at the same time keep all the disease-
related data variability. Third method studied, which, to the best
of our knowledge has not been studied previously on medical data,
was the combination of these two methods. The evaluation of the
methods was based on classification results of an automatic
machine learning method (sequential stepwise feature selection
and regression classifier). In clinical decision support systems, the
knowledge obtained in this study can be used to generate data,
either in textual or graphical format, where the differences
between study groups are pronounced.
The objective of this paper was to study the methods for
removing the effects on nuisance features from the classification
data in order to get the optimal gain for the personalized
healthcare and medicine. The example application for which the
methods were validated was the diagnosis of AD. The results show
that significant improvements in the classification of AD data are
obtained using the methods studied.
Materials and Methods
Subjects
Data used in the preparation of this article were obtained from
the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
(adni.loni.ucla.edu). The ADNI was launched in 2003 by the
National Institute on Aging (NIA), the National Institute of
Biomedical Imaging and Bioengineering (NIBIB), the Food and
Drug Administration (FDA), private pharmaceutical companies
and non-profit organizations, as a $60 million, 5-year public-
private partnership. The primary goal of ADNI has been to test
whether serial magnetic resonance imaging, positron emission
tomography, other biological markers, and clinical and neuropsy-
chological assessment can be combined to measure the progression
of mild cognitive impairment and early Alzheimer’s disease.
Determination of sensitive and specific markers of very early AD
progression is intended to aid researchers and clinicians to develop
new treatments and monitor their effectiveness, as well as lessen
the time and cost of clinical trials. The Principal Investigator of
this initiative is Michael W. Weiner, MD, VA Medical Center and
University of California – San Francisco. ADNI is the result of
efforts of many co- investigators from a broad range of academic
institutions and private corporations, and subjects have been
recruited from over 50 sites across the U.S. and Canada. The
initial goal of ADNI was to recruit 800 adults, ages 55 to 90, to
participate in the research – approximately 200 cognitively normal
older individuals to be followed for 3 years, 400 people with MCI
to be followed for 3 years and 200 people with early AD to be
followed for 2 years.
In the ADNI database, the subjects are classified into three
groups: healthy controls, MCI subjects, and AD subjects. There is
also follow-up information on the conversion events (MCI to AD,
Control to MCI or AD). For this study, four groups were
established: controls (C), stable MCIs (SMCI), progressive MCIs
(PMCI), and subjects with Alzheimer’s disease (AD). The SMCI
group consisted of the subjects with MCI at baseline and no
known conversion to AD. The PMCI subjects had MCI at
baseline, and known conversion to AD during the study time. The
total number of subjects was 786. The demographics of the
subjects are shown in Table 1.
Features
There are about 3000 features in the ADNI database. These
features include, for example, demographic data, results of
neuropsychological tests, molecular tests, and imaging studies. In
this study, we selected nine feature groups for the analysis. A set of
neuropsychological tests (both raw scores of individual tests and
total scores) and biomarkers from imaging studies (original data,
not normalized for brain size), which were known to be among the
best ones for the classification of AD data, were selected. Also, the
APOE genotype (number of APOE a4 alleles) was used. The
feature groups are listed in Table 2. In order to focus on the most
interesting features and features for which there are not many
missing values, a pre-selection of the features was performed. A
feature was excluded, if there was more than 10% values missing,
and if the p-value of the t-test (data were assumed to be normally
distributed) for the two study groups was above a threshold. This
threshold was 0.00001 for C vs. AD comparison and 0.01 for
SMCI vs. PMCI comparison. The values were chosen so that
approximately as many classification features were used in both
Table 1. Demographic data (mean 6 standard deviation, or
%) of subjects.
C SMCI PMCI AD Total
N 217 222 156 191 786
Age (years) 76.065.1 75.167.6 74.666.9a 75.467.5 75.366.8
Females (%) 48.30% 33.3%
a 40.40% 47.6%
b 42.40%
Education
(years)
16.162.8 15.663.2 15.762.9 14.763.1
a,b,c 15.663.1
MMSE 29.161.0 27.361.8
a 26.761.7
a,b 23.362.1
a,b,c 26.762.7
Conversion time
(months)
18.269.0
astatistically significantly different from controls, p,0.05.
bstatistically significantly different from SMCI, p,0.05.
cstatistically significantly different from PMCI, p,0.05.
t-test for age, education and MMSE, chi-square test for percentage of females.
doi:10.1371/journal.pone.0031112.t001
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group after the pre-selections are shown in Table 2. The data used
in this study were the baseline features (either screening or baseline
measurements).
For the data correction and stratification, eight nuisance
features were selected. The features are listed in Table 3. They
are demographic data or clinical measures that can be easily
obtained and that are not by themselves good classification
features.
Data correction and stratification methods
The need for data correction or stratification methods to
remove the effects of a nuisance feature is demonstrated in
Figure 1, where the volume of left hippocampus is shown as a
function of age and separately for males and females. In this
example, there is a strong correlation between the nuisance and
classification features. The average hippocampus volume of 90-
years old healthy persons is close to the average volume of 55-years
old AD patients. On the other hand, if the comparison is
performed to the 90-years old AD subjects, the difference is
evident. Therefore, by removing the age-related effect, either using
data correction or data stratification, the separation of groups in
the classification data is enlarged and classification accuracy is
improved.
Data correction using regression model. As in the
ANCOVA, the data correction was implemented using a linear
regression model. The method was based on the data variability in
the healthy controls because in this group there should not be any
disease related variability, as proposed recently in [15]. The
normal data variability, for example as a function of age or gender,
was first modeled using regression model, and then this effect was
removed from all the data using the model obtained.
Based on initial studies, we made an assumption on the linearity
of the relations between the nuisance features and the classification
features (e.g., Figure 1). Let us denote the value of ith classification
feature as ci, and the value of jth nuisance feature as sj.
Classification features are the individual features of the feature
groups presented in Table 2, and the nuisance features are the
features listed in Table 3.
The linear relation between classification feature ci and nuisance
feature sj can be modeled using a linear regression model
ci~aijzbijsj ð1Þ
where regression parameters aij and bij are unique for each
classification–nuisance feature pair and determined as
min
aij,bij
X
n
ci(n){ aijzbijsj(n)
          
 !
, n[control group: ð2Þ
Notations ci(n) and sj(n) denote the values of classification and
nuisance features, respectively, for a subject n. The corrected
values ~ c ci(n) of the classification feature ci corrected for the
nuisance feature sj are obtained from
~ c ci(n)~ci(n){ aijzbij:sj(n)
  
: ð3Þ
The corrected values of the control group have zero mean. To
produce values similar to the original values, for example, the
mean value of the control group could be added to the corrected
values. Alternatively, the training set used in the classification can
be corrected to correspond with the values of the patient. It is
straightforward to extend this method to include many nuisance
features.
Figure 2 demonstrates the method using left hippocampus
volume as the classification feature and age and gender as the
nuisance features. In the original data (Figure 2A), clear trend for
Table 2. Feature groups used in the analysis, and the number of features after pre-selections.
Feature Group Abbreviation C vs. AD SMCI vs. PMCI
ADAS Sub-Scores and Total Scores ADAS 24 9
Clinical Dementia Rating CDR 7 3
Functional Assessment Questionnaire FAQ 12 10
Mini Mental State Examination MMSE 16 2
Neuropsychological Battery NB 40 21
Cross-Sectional FreeSurfer FS 119 93
Derived Volumes DV 14 13
SPM voxel based morphometry analysis VBM 65 2
APOE e4 alleles APOE 1 1
doi:10.1371/journal.pone.0031112.t002
Table 3. Nuisance features and classification accuracies using each nuisance feature to classify all the data.
Gender Age Education Weight Alcohol Smoking BPsyst Cholesterol
C vs. AD 0.45 0.48 0.59 0.57 0.54 0.54 0.52 0.52
SMCI vs. PMCI 0.57 0.52 0.43 0.52 0.50 0.47 0.51 0.53
Education=Years of education, Alcohol=Alcohol abuse (yes/no), Smoking=Smoking (yes/no), BPsyst=Systolic blood pressure (mmHg), Cholesterol=Cholesterol (High
performance).
doi:10.1371/journal.pone.0031112.t003
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volumes than males. First, a linear model is fit to the data of
control subjects (both male and female). Then the data are
corrected based on the linear model (Figure 2B), which removes
most of the age-related data variability (the lines are almost
horizontal). However, there are clear differences between males
and females. When the correction is done by utilizing both the
differences in age and gender (Figure 2C), there is no age- or
gender-related variability in the control group, and also in AD
group such variability has decreased notably. Consequently, the
control and AD groups are better separated and the probability
distributions (Figure 2D) are narrower and have higher peaks,
which improves the classification accuracy.
Data stratification. In data stratification, a subset of the
subjects is selected so that they establish a more uniform population
than all the subjects together. In this study, a subset of the dataset
subjects was selected for a target subject n based on the rule
sj(n){sj(m)
       vthj, m[ training set, ð4Þ
where thj is a user-defined threshold for the nuisance feature sj.I f
multiple nuisance features are used, they all have to fulfill the rule
Figure 1. Mean left hippocampus volumes and standard errors as a function of age (males and females) and gender (for all ages).
doi:10.1371/journal.pone.0031112.g001
Figure 2. Example of data correction. Left hippocampus volume is used as the classification feature and age and gender as nuisance features. A:
Original data (zero mean for visualization). B: Data corrected for age. C: Data corrected for age and gender. D: Probability distributions (Parzen
widowing) for all three data. Lines visualize the linear fits for each group.
doi:10.1371/journal.pone.0031112.g002
Improved Classification of Alzheimer’s Disease
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31112above. The threshold thj was determined as a?std(sj), i.e., as a
multiple of the standard deviation of the nuisance feature in the
whole dataset. Different values for a were tested, and the results are
presented for a=1which gave on average the best results.
The data stratification strategy is demonstrated in Figure 3. The
example is the same as above for the data correction. In this
example, it was assumed that the target subject was an 85 years old
female. The subjects selected in the training set for the particular
target subject are shown in black markers in Figure 3A. The
probability density functions in Figure 3B show that when the
stratification is done using only age, the volumes of the training sets
are smaller and the probability density functions are sharper as
compared to the original dataset. When the stratification is done
using both age and genderthe distributionsare even more localized.
The differences between data stratification and data correction
can be seen in the probability density functions in Figures 2D and
3B. Data stratification is able to make much larger changes in the
probability distributions of the training sets. Consequently, if the
target subject data match with the new distributions the data
stratification should give better results. However, the number of
training set samples is much smaller in the data stratification (e.g.,
N=61 for data stratification in Figure 3 and N=408 for data
correction in Figure 2). This can be seen as smoother distributions
in Figure 2D as compared to distributions in Figure 3B. When
multiple stratification features are used, the number of training set
subjects selected may be so small that a classifier, especially if high-
dimensional classifiers are used, cannot be efficiently trained. One
option to handle this problem would be to always use at least N
closest samples in data stratification. However, for binary and
ordinal features, such as sex, genotypes etc., such an approach is
not straightforward. In this study, all the subjects were used if the
number of subjects in both study groups after the data
stratification was less than 10, i.e., no data stratification was
performed in those cases.
Combination of data correction and stratification. Data
correction and data stratification can be easily combined: first,
data stratification is performed, and then the data selected are
corrected. The data correction could be done using the stratified
data only. However, as the number of samples after the
stratification may be very small the estimation of the regression
parameters may become inaccurate. Also, as the relationships
between nuisance and classification features were assumed to be
linear, the same regression parameters should be applicable for
each stratified subset. Consequently, in this study we decided to
make the data correction from the whole dataset in order to
guarantee large enough number of samples.
Types of interactions of nuisance and classification
features
Four kinds of possible interactions between nuisance features
and classification features were discovered as a result of general
reasoning. These are demonstrated using synthetic examples in
Figure 4 and real-world examples in Figure 5.
Type 0. In Type 0, there is no relation between nuisance and
classification features. Therefore, neither data correction nor
stratification is needed for this pair of nuisance and classification
features (Figure 5A).
Type 1. In Type 1, there is no relation between nuisance
feature and classification feature. However, the probability of
belonging to a specific group is related to the value of the nuisance
feature. In Figure 4, if a subject has a large value for nuisance
feature, it is very likely that the subject is from the red group. In
this case, the nuisance feature actually works as a classification
feature, and should not be used in data correction or data
stratification. No real-world example is shown for this type as the
nuisance features were selected so that they cannot be used as a
classification feature.
Type 2. If there is a direct functional relationship between the
classification feature ci and the nuisance feature sj so that it can be
modelled as ci=f(sj), it is possible to use either data correction or
stratification to remove the effect of nuisance feature.
Theoretically, the underlying (unknown) distribution for the
classification feature can be defined best by modelling the
functional relationship and removing its effect from the classifica-
tion feature values as in Eq 3. This way, all control subjects are
used to estimate the classifier. However, in practice the underlying
model can rarely be perfectly modelled and some error is
introduced to the classifier. On the other hand, if stratification is
used instead of modelling and a portion of the training data is left
out, the expected classifier estimate would be erroneous due to the
smaller sample size. Thus, it depends on the case which method is
better suitable to nuisance effect correction.
As a rule of thumb, if there are a ‘‘large’’ number of subjects in
the stratified control group or the functional relationship between
the feature and the nuisance parameter is unclear, stratification
should work better. With a smaller number of subjects and with an
obvious functional relationship, the correction through regression
modelling should be preferred. In the example in Figure 5B both
the data correction and data stratification improved the classifi-
cation accuracy as compared to the original feature values.
Type 3. In the last type of interaction, the separation of the
two groups differs depending on the value of a nuisance feature.
However, there is no relationship between the classification feature
Figure 3. Example of data stratification. Only the subjects marked with black markers are used to train a classifier for a target subject (85 years
old female).
doi:10.1371/journal.pone.0031112.g003
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work. On the other hand, data stratification can improve the
classification accuracy for those nuisance feature values for which
the groups are well separated. This behaviour is demonstrated in
Figure 5C where especially in the classification of SMCI and
PMCI subjects data stratification outperforms data correction.
When real-world data are analyzed, it is unlikely that any of the
single types of interactions would be able to model all the
interactions in the data. This motivates the use of the combination
of data correction and stratification methods.
Classification methods
The main objectives of this study were to compare data
correction and data stratification methods, and to compare
potential nuisance features to be used in data correction or
stratification in the area of AD diagnosis. In order to keep the
results easily interpretable, we chose to use a simple and well-
known classification method, linear regression classifier. Each
feature group was used separately to classify the data. Conse-
quently, the number of features in the classification varied between
one and 119 (see Table 2). Therefore, feature selection was used to
avoid over-learning of classifiers.
Feature selection. In multi-dimensional classification, the
performance of classifiers suffers if many features with little value
for classification are included. The classifier tries to explain the
variations in these features, and the real important information
cannot be modeled accurately. Therefore, feature selection was
utilized to find the optimal set of features. We used here sequential
step-wise selection (Matlab’s ‘‘stepwisefit’’ function, Matlab
R2010b, The MathWorks Inc.). In the beginning, no features
are in the model, and the features are added or removed one by
one. The feature with the smallest p-value (if p,0.05, F-statistics)
is added to the model, and if there is a feature with a p-value larger
than 0.1 it is removed.
Regression classifier. We selected as a classifier a linear
regression classifier because it is generally used and simple
classifier. It is well suitable for both single-and multi-feature
classification, and does not require optimization of any
parameters.
There is a misbalance in the sizes of the study groups, especially
between SMCI and PMCI groups (Table 1). In order to guarantee
that the classifier actually classifies the data based on the
classification features, not just assign the class of the largest study
group to all the subjects, synthetic samples were generated from
the smaller group using the SMOTE method [16] so that equal
number of samples were used from both study groups.
Evaluation procedure
In this paper, two classification studies were performed. In the
first study, control subjects and AD patients were classified. This
reveals basic information on the changes that take place due to
the disease. However, because some feature groups, such as
Mini Mental State Exam (MMSE) and Clinical Dementia
Rating (CDR), are utilized in making the diagnosis, the
classification results using these neuropsychological tests are
biased. The second classification study was performed between
stable and progressive MCI subjects. This is clinically a much
more relevant study for the early detection of the disease. If the
MCI subjects that will develop AD are detected early,
treatments will be more effective and the costs of the disease
are reduced.
The evaluation was performed using leave-N-out cross-valida-
tion: 90% of subjects were randomly selected to a training set and
the remaining 10% established the test set. In data correction, the
linear model was first learned from the training set, and the
classifier was trained using the corrected values of the training set.
Then, the classifier was applied to the corrected values of the test
set subjects. In data stratification, each test set subject was
individually classified by performing the stratification from the
training set and training the classifier with the selected subset of
the training set. This was repeated 100 times each time randomly
selecting the training and test sets, and the classification results
were averaged. The random training and test sets were the same
for all the studies performed. Therefore, the results obtained can
be pair-wise compared.
First, the classifications were performed without data correction
or data stratification to establish reference results. Then all the
combinations of nuisance features were studied. In other words,
Figure 4. Types of relations between nuisance features and classification features.
doi:10.1371/journal.pone.0031112.g004
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combinations of two features were studied etc. For each
combination of nuisance features, the data correction, data
stratification, and their combination were tested.
The evaluation was performed by measuring classification
accuracy (Acc):
Acc~
total number of correct classifications
total number of test set subjects
: ð5Þ
Acc=1 if all the test set subjects have been correctly classified and
Acc=0 if all have been misclassified. Statistical comparisons of
Figure 5. Real-world examples of the three types of interactions between a nuisance feature and a classification feature. A: Type 0. B:
Type 2. C: Type 3. In the figures, the local average values and mean errors of the classification features are shown as a function of a nuisance feature.
In addition, the classification accuracy for each classification feature is shown for the original data (Orig), corrected feature values (Corr), stratified
analysis (Strat), and combination of data correction and stratification (Comb).
doi:10.1371/journal.pone.0031112.g005
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threshold for significance was set at p,0.05.
Results
The classification results without data correction or stratification
for each feature group are presented in Table 4 (column original).
As assumed, the neuropsychological tests gave clearly the best
results for the C vs. AD classification, with accuracy close to 100%.
The best MRI-based feature group (DV) reached classification
accuracy of 87%. For the classification of stable and progressive
MCIs, the best results (67%) were obtained using neuropsycho-
logical test NB and the best imaging feature group was DV (65%).
The best results for the data correction, stratification, and their
combination for single nuisance features are also shown in Table 4.
In the C vs. AD classification, statistically significant improvements
were observedfor all the MRI-based feature groups, in which the
classification accuracy improved 1–2% units. Data stratification
gave statistically significant improvement when using CDR and
MMSE tests. Data stratification gave on average slightly worse
results than data correction. Both methods were able to always
give at least as good accuracy as the original data. The
combination of data correction and data stratification did not
give any statistically significant improvement, as compared to the
better one of the data correction and data stratification methods
alone. In the SMCI vs. PMCI classification, data correction
improved the classification accuracy statistically significantly for all
the MRI-based feature groups, and the improvement was 2–5%
units. Data stratification improved the results of several neuro-
psychological tests (CDR 5% units, FAQ 2% units, and MMSE
4% units). The improvements of the MRI feature groups in data
stratification were between 1–3% units. Combination of the two
methods was not able to further improve classification accuracy.
Table 5 summarizes the results for the optimal combinations of
nuisance features. The results for C vs. AD classification were
similar to the result using only one nuisance feature. Data
correction was able to improve the results of MRI-based feature
groups. The improvement was 2–3% units, i.e., slightly better than
with a single feature. The results of data stratification were almost
similar to the results with a single nuisance feature, and the
combination did not improve the results of data correction and
data stratification alone. For the SMCI vs. PMCI classification, the
utilization of many nuisance features improved the results more.
For the MRI feature groups the improvement using data
correction was 4–6% units, and for the neuropsychological tests
using data stratification 2–6% units. The combination of data
correction and stratification was able to give a small, but
statistically non-significant, improvement to some feature groups.
Figure 6 shows how classification accuracy changed when more
nuisance features were added: it increased at first, but after
reaching the optimum it began to decrease. Therefore, all the
nuisance features should not be used.
The results in Tables 4 and 5 give the results for the optimal
combination of nuisance features, but as these results are usually
obtained with different sets of nuisance features additional
guidelines are needed for future studies. Various sets of nuisance
features produce results that are close to the optimal results.
Consequently, it is useful to define one set of nuisance features that
can be used in all the studies. However, the behaviour of
neuropsychological tests and MRI biomarkers are different.
Therefore, different future guidelines are needed for neuropsy-
chological tests and imaging biomarkers. When performing
Table 4. Classification accuracies with single nuisance feature.
C vs. AD original correction stratification combination
ADAS 0.96 0.96 (Gender) 0.96 (Smoking) 0.96 (Smoking)
CDR 0.97 0.97 (Weight) 0.98* (Gender) 0.98* (Gender)
FAQ 0.96 0.96 (Cholesterol) 0.96 (Alcohol) 0.96 (Alcohol)
MMSE 0.95 0.95 (Smoking) 0.95* (Weight) 0.95* (Weight)
NB 0.99 0.99 (Cholesterol) 0.99 (Cholesterol) 0.99* (Age)
FS 0.85 0.87* (Age) 0.85 (Alcohol) 0.85 (Alcohol)
DV 0.87 0.88* (Age) 0.87 (Alcohol) 0.87 (Age)
VBM 0.75 0.76* (Age) 0.75 (Education) 0.76 (Education)
APOE 0.69 0.69 (Gender) 0.69 (Gender) 0.69 (Gender)
SMCI vs. PMCI original correction stratification combination
ADAS 0.64 0.64 (Education) 0.65 (Weight) 0.65 (Weight)
CDR 0.58 0.58 (Gender) 0.63* (Gender) 0.63* (Gender)
FAQ 0.63 0.64 (Cholesterol) 0.65* (Education) 0.65* (Education)
MMSE 0.60 0.61* (Education) 0.64* (Gender) 0.64* (Gender)
NB 0.67 0.68 (Cholesterol) 0.66 (Alcohol) 0.66 (Smoking)
FS 0.60 0.62* (Age) 0.61* (Smoking) 0.62* (Age)
DV 0.65 0.69* (Age) 0.67* (Age) 0.68* (Age)
VBM 0.51 0.56* (Age) 0.54* (Age) 0.56* (Age)
APOE 0.61 0.61 (Gender) 0.61 (Age) 0.61 (Age)
Classification accuracies without data correction or stratification (original) and the best accuracies when using a single nuisance feature. The feature producing the best
result is shown in parenthesis.
*statistically significantly better (p,0.05, t-test) as compared to the results with the original data.
doi:10.1371/journal.pone.0031112.t004
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gender, and education in data correction gave good results for all
the MRI feature groups (C vs. AD: 0.88 for FS, 0.89 for DV, 0.76
for VBM, SMCI vs. PMCI: 0.63 for FS, 0.69 for DV, 0.55 for
VBM). In all these cases the results were statistically significantly
improved from the classification without data correction or
stratification. For the neuropsychological tests such single
guideline could not be determined, but it is suggested to use the
best single nuisance features reported in Table 4, i.e., gender for
CDR and MMSE and education for FAQ using the combination
of data correction and stratification.
To give some idea on the effect of data correction for the
performance of single features, Table 6 shows the results for each
feature from the DV feature group for data correction using
gender, age, and education as nuisance features. Almost all the
features improved the results in data correction. In the SMCI vs.
PMCI classification there is a trend that the improvement is larger
for the structures that give the worst results using the original data.
Discussion
In this paper, data correction and data stratification were tested
for the classification of Alzheimer’s disease data. Eight features
were used as nuisance features, and the classifications were
performed using data obtained from the ADNI database. The
classification data included neuropsychological tests, MRI analy-
ses, and APOE genotype values.
The results show that in the best case up to 6% units
improvement in the classification accuracy can be achieved with
data correction and stratification. The biggest improvements were
obtained in the classification of stable and progressive MCI
subjects, which is the most challenging and interesting classifica-
Figure 6. Classification accuracies and mean errors for optimal sets of n nuisance features. A: Data correction method applied to DV for C
vs. AD classification, B: Data stratification method applied to CDR for SMCI vs. PMCI classification.
doi:10.1371/journal.pone.0031112.g006
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PLoS ONE | www.plosone.org 10 February 2012 | Volume 7 | Issue 2 | e31112tion problem in the analysis of Alzheimer’s disease. The
classification accuracy was improved in all imaging and neuro-
psychological feature groups studied. In the classification of
controls from AD patients, the largest improvements were
obtained for the MRI-based feature groups. However, neuropsy-
chological tests are biased in this comparison as they are already
used in the clinical diagnosis, so their results are not very
interesting. The data correction method gave better results for
imaging biomarkers, whereas data stratification worked well with
the neuropsychological tests. The combination of data correction
and stratification was not able to further improve the results.
Guidelines for the future studies were presented based on the
results obtained in this study.
The weakness of data stratification, especially when numerous
nuisance features are used, is that the number of training samples
decreases which affects the performance of the classifier. This can
be seen in Figure 5A, where data stratification gives worse results
than the original data. On the other hand, data correction always
utilizes the full data set, and, therefore, it is guaranteed that the
maximum amount of data is available for the training of a
classifier. In addition, data stratification requires one parameter to
be chosen. The threshold th for the inclusion criteria was selected
in this study as the standard deviation of the feature values.
However, the threshold used here may not be optimal, and further
studies are needed to find out how this value should be defined.
The data correction method used in this paper was based on
linear regression model. We have tested also regression model with
the cross-terms, but the results were worse than the results
presented in this paper. The method can be easily extended to any
higher order polynomials, or other basic functions. However, the
more complex the model used the larger training set is required in
order to reliable estimate the values for the parameters.
In this paper, we identified four types of interactions between
nuisance features and classification features. Different interactions
and their combinations need different correction and stratification
methods. In this study, the interactions were not detected from the
data, but in an optimal situation, the types of interactions are
detected for each classification-nuisance feature pair, and the
method used is determined based on the type detected. The types
could be detected, for example, by studying the results of line
fitting and statistical tests, performed either for the whole space of
nuisance feature values or for a specific range of values.
The results presented in this study were obtained using linear
regression classifier. All the studies were performed also using
naı ¨ve Bayesian classifier, linear discriminant analysis, and support
vector machines (SVM). These methods produced results similar
to the ones presented in this paper. A regression classifier was
selected because it is the simplest one from the classifiers studied
and does not require optimization of any parameters. For
example, SVM could give slightly better classification results but
the choice of kernel type and parameter values should be
optimized separately for each feature group used. The failure of
using optimal kernels and parameters could decrease the results
dramatically.
One weakness of the study may be the feature selection used. In
some feature groups there were tens of features, and therefore,
efficient feature selection is required. Only one standard method
was tested for the feature selection in this study. A state-of-the art
feature selection might give some extra improvement in the results.
There are many kinds of features in the ADNI database
(continuous, binary, ordinal, nominal etc…). The methods
presented here can be used for all the features that are ordered.
Data stratification can be used also for non-ordered data if the
thresholds are reasonably selected. The data correction method is
best suitable for continuous classification features. In the case of
binary or ordinal features large corrections are required to change
the classification feature value so that it would affect the
classification result. In this study, it was shown that data correction
suits for continuous imaging biomarkers, whereas data stratifica-
tion works well for neuropsychological tests where there are many
binary variables. Consequently, different methods for different
feature types should be further studied.
The benefit of the methods studied here is that in the clinical
decision making, for example using the tool presented in [17], a
clinician can visually compare the patient values to either
corrected values in a dataset or to the values of a stratified
dataset. In the stratified/corrected feature values the group
differences are better visible and, consequently, the diagnosis can
be performed more reliably. Most of the methods presented in the
literature, such as ANCOVA, handle the patient values in a black
Table 6. Classification results for single features from the DV feature group.
C vs. AD, original C vs. AD, corrected SMCI vs. PMCI, original SMCI vs. PMCI, corrected
Whole Brain 0.60 0.63 0.55 0.60
Ventricles 0.65 0.67
Right Inferior Lateral Ventricle 0.70 0.74 0.60 0.62
Left Middle Temporal 0.75 0.79 0.63 0.63
Left Inferior Lateral Ventricle 0.73 0.75 0.57 0.59
Left Hippocampus 0.79 0.82 0.61 0.64
Right Hippocampus 0.76 0.79 0.61 0.63
Left Fusiform 0.76 0.77 0.59 0.62
Right Fusiform 0.74 0.75 0.62 0.63
Right Inferior Temporal 0.74 0.75 0.64 0.65
Right Middle Temporal 0.74 0.76 0.65 0.64
Left Inferior Temporal 0.79 0.79 0.61 0.64
Left Entorhinal 0.82 0.84 0.60 0.61
Right Entorhinal 0.80 0.80 0.63 0.63
doi:10.1371/journal.pone.0031112.t006
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PLoS ONE | www.plosone.org 11 February 2012 | Volume 7 | Issue 2 | e31112box and only output a classification result that is not very
informative in clinical decision making.
In this paper, the evaluation of the methods was performed
using automatic classification methods in order to be able to use
large dataset. An alternative approach would have been to give the
original and corrected or stratified data to a clinician and asked
him/her to make the diagnosis using the data available. Only a
small dataset could have been evaluated using this approach, and
all the combinations of nuisance features could not have been
analyzed. Nevertheless, this study gave valuable information how
the personalized diagnostics in AD could be performed. As the
next step, this knowledge should be validated in clinical
environment.
The methods proposed here can be used as a pre-processing
step to improve the classification accuracy of any combination of
feature selection and classification methods. In addition, the
methods studied in this paper are not specific to Alzheimer’s
disease, but can be applied to any medical application, and also
outside the medical field.
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